World's Most Affordable Favipiravir at 33Rs

APIs, excipients and FDFs housed in new-age, eco-sustainable storage

Chairman's message

Thank you for taking the time to visit our website. Keeping pace with rapid global pharmaceutical industry evolution, MSN Labs is constantly realigning and streamlining its business objectives and operations to meet the ever-changing requirements of global markets. As a dynamic organisation, I see many promising opportunities for MSN Group in the years ahead. And I am hopeful that we will continue to serve the world by bringing affordable medicines within everyone’s reach.

Read More

Our Services

API

One of the fastest growing pharmaceutical companies in the country, MSN Laboratories has 14 API facilities, including oncology.

Formulations

We have exemplified complex drug development that is economically feasible - making MSN Laboratories World No. 1 in active DMFs.

CRAMS

MSN group has been a pivotal provider with a record of 50 first to file ANDA’s and 30+ first - to - launch generics across the world.

Our ever-growing portfolio

We are extremely grateful for the wonderful family of clients and customers that we have built across the globe.

Latest Events

Corporate Video

Follow us on Facebook

Follow us on Facebook